227 related articles for article (PubMed ID: 21979949)
1. Oligomerization of DNMT3A controls the mechanism of de novo DNA methylation.
Holz-Schietinger C; Matje DM; Harrison MF; Reich NO
J Biol Chem; 2011 Dec; 286(48):41479-41488. PubMed ID: 21979949
[TBL] [Abstract][Full Text] [Related]
2. The R882H substitution in the human
Sandoval JE; Reich NO
J Biol Chem; 2019 Nov; 294(48):18207-18219. PubMed ID: 31640986
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the DNMT3A DNA methyltransferase in acute myeloid leukemia patients cause both loss and gain of function and differential regulation by protein partners.
Sandoval JE; Huang YH; Muise A; Goodell MA; Reich NO
J Biol Chem; 2019 Mar; 294(13):4898-4910. PubMed ID: 30705090
[TBL] [Abstract][Full Text] [Related]
4. Functional Analysis of DNMT3A DNA Methyltransferase Mutations Reported in Patients with Acute Myeloid Leukemia.
Khrabrova DA; Loiko AG; Tolkacheva AA; Cherepanova NA; Zvereva MI; Kirsanova OV; Gromova ES
Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31861499
[TBL] [Abstract][Full Text] [Related]
5. Recurrent DNMT3A mutations in patients with myelodysplastic syndromes.
Walter MJ; Ding L; Shen D; Shao J; Grillot M; McLellan M; Fulton R; Schmidt H; Kalicki-Veizer J; O'Laughlin M; Kandoth C; Baty J; Westervelt P; DiPersio JF; Mardis ER; Wilson RK; Ley TJ; Graubert TA
Leukemia; 2011 Jul; 25(7):1153-8. PubMed ID: 21415852
[TBL] [Abstract][Full Text] [Related]
6. Oligomerization and binding of the Dnmt3a DNA methyltransferase to parallel DNA molecules: heterochromatic localization and role of Dnmt3L.
Jurkowska RZ; Rajavelu A; Anspach N; Urbanke C; Jankevicius G; Ragozin S; Nellen W; Jeltsch A
J Biol Chem; 2011 Jul; 286(27):24200-7. PubMed ID: 21566127
[TBL] [Abstract][Full Text] [Related]
7. Mutations in DNA methyltransferase (DNMT3A) observed in acute myeloid leukemia patients disrupt processive methylation.
Holz-Schietinger C; Matje DM; Reich NO
J Biol Chem; 2012 Sep; 287(37):30941-51. PubMed ID: 22722925
[TBL] [Abstract][Full Text] [Related]
8. The inherent processivity of the human de novo methyltransferase 3A (DNMT3A) is enhanced by DNMT3L.
Holz-Schietinger C; Reich NO
J Biol Chem; 2010 Sep; 285(38):29091-100. PubMed ID: 20630873
[TBL] [Abstract][Full Text] [Related]
9. The R882H DNMT3A hot spot mutation stabilizes the formation of large DNMT3A oligomers with low DNA methyltransferase activity.
Nguyen TV; Yao S; Wang Y; Rolfe A; Selvaraj A; Darman R; Ke J; Warmuth M; Smith PG; Larsen NA; Yu L; Zhu P; Fekkes P; Vaillancourt FH; Bolduc DM
J Biol Chem; 2019 Nov; 294(45):16966-16977. PubMed ID: 31582562
[TBL] [Abstract][Full Text] [Related]
10. Dnmt3b Methylates DNA by a Noncooperative Mechanism, and Its Activity Is Unaffected by Manipulations at the Predicted Dimer Interface.
Norvil AB; Petell CJ; Alabdi L; Wu L; Rossie S; Gowher H
Biochemistry; 2018 Jul; 57(29):4312-4324. PubMed ID: 27768276
[TBL] [Abstract][Full Text] [Related]
11. DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia.
Ferreira HJ; Heyn H; Vizoso M; Moutinho C; Vidal E; Gomez A; Martínez-Cardús A; Simó-Riudalbas L; Moran S; Jost E; Esteller M
Oncogene; 2016 Jun; 35(23):3079-82. PubMed ID: 26434589
[TBL] [Abstract][Full Text] [Related]
12. Structure-guided functional suppression of AML-associated DNMT3A hotspot mutations.
Lu J; Guo Y; Yin J; Chen J; Wang Y; Wang GG; Song J
Nat Commun; 2024 Apr; 15(1):3111. PubMed ID: 38600075
[TBL] [Abstract][Full Text] [Related]
13. Rare occurrence of DNMT3A mutations in myelodysplastic syndromes.
Thol F; Winschel C; Lüdeking A; Yun H; Friesen I; Damm F; Wagner K; Krauter J; Heuser M; Ganser A
Haematologica; 2011 Dec; 96(12):1870-3. PubMed ID: 21880636
[TBL] [Abstract][Full Text] [Related]
14. Forced expression of DNA methyltransferases during oocyte growth accelerates the establishment of methylation imprints but not functional genomic imprinting.
Hara S; Takano T; Fujikawa T; Yamada M; Wakai T; Kono T; Obata Y
Hum Mol Genet; 2014 Jul; 23(14):3853-64. PubMed ID: 24599402
[TBL] [Abstract][Full Text] [Related]
15. AML-Associated Mutations in DNA Methyltransferase DNMT3A.
Khrabrova DA; Yakubovskaya MG; Gromova ES
Biochemistry (Mosc); 2021 Mar; 86(3):307-318. PubMed ID: 33838631
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of stimulation of catalytic activity of Dnmt3A and Dnmt3B DNA-(cytosine-C5)-methyltransferases by Dnmt3L.
Gowher H; Liebert K; Hermann A; Xu G; Jeltsch A
J Biol Chem; 2005 Apr; 280(14):13341-8. PubMed ID: 15671018
[TBL] [Abstract][Full Text] [Related]
17. DNMT3L stimulates the DNA methylation activity of Dnmt3a and Dnmt3b through a direct interaction.
Suetake I; Shinozaki F; Miyagawa J; Takeshima H; Tajima S
J Biol Chem; 2004 Jun; 279(26):27816-23. PubMed ID: 15105426
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for DNMT3A-mediated de novo DNA methylation.
Zhang ZM; Lu R; Wang P; Yu Y; Chen D; Gao L; Liu S; Ji D; Rothbart SB; Wang Y; Wang GG; Song J
Nature; 2018 Feb; 554(7692):387-391. PubMed ID: 29414941
[TBL] [Abstract][Full Text] [Related]
19. The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers.
Russler-Germain DA; Spencer DH; Young MA; Lamprecht TL; Miller CA; Fulton R; Meyer MR; Erdmann-Gilmore P; Townsend RR; Wilson RK; Ley TJ
Cancer Cell; 2014 Apr; 25(4):442-54. PubMed ID: 24656771
[TBL] [Abstract][Full Text] [Related]
20. DNMT3A alterations associated with myeloid malignancies dictate differential responses to hypomethylating agents.
Casellas Román HL; Venugopal K; Feng Y; Shabashvili DE; Posada LM; Li J; Guryanova OA
Leuk Res; 2020 Jul; 94():106372. PubMed ID: 32445940
[No Abstract] [Full Text] [Related]
[Next] [New Search]
